Hall Laurie J Trustee Atara Biotherapeutics, Inc. Transaction History

Hall Laurie J Trustee

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$2.85 - $8.73 $299 - $916	-105 Reduced 30.88%	235 $1,000
Q3 2021 Oct 04, 2021	SELL	$11.99 - $17.9 $2,637 - $3,937	-220 Reduced 39.29%	340 $6,000
Q3 2020 Oct 09, 2020	BUY	$11.92 - $15.87 $3,337 - $4,443	280 Added 100.0%	560 $7,000
Q4 2019 Feb 12, 2020	BUY	$10.89 - $16.79 $3,049 - $4,701	280 New	280 $5,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.